Donald A. Berry

1978–2025 年に発表

175
論文数
51,167
被引用数
104
h 指数
173
i10 指数

被引用数

Donald A. Berry の年別被引用数1967 年: 被引用 1 件1971 年: 被引用 2 件1980 年: 被引用 2 件1981 年: 被引用 4 件1982 年: 被引用 4 件1983 年: 被引用 2 件1984 年: 被引用 1 件1985 年: 被引用 3 件1986 年: 被引用 9 件1987 年: 被引用 5 件1988 年: 被引用 12 件1989 年: 被引用 9 件1990 年: 被引用 19 件1991 年: 被引用 21 件1992 年: 被引用 29 件1993 年: 被引用 19 件1994 年: 被引用 42 件1995 年: 被引用 60 件1996 年: 被引用 49 件1997 年: 被引用 62 件1998 年: 被引用 75 件1999 年: 被引用 72 件2000 年: 被引用 111 件2001 年: 被引用 132 件2002 年: 被引用 122 件2003 年: 被引用 174 件2004 年: 被引用 196 件2005 年: 被引用 258 件2006 年: 被引用 298 件2007 年: 被引用 314 件2008 年: 被引用 300 件2009 年: 被引用 377 件2010 年: 被引用 378 件2011 年: 被引用 318 件2012 年: 被引用 334 件2013 年: 被引用 329 件2014 年: 被引用 365 件2015 年: 被引用 425 件2016 年: 被引用 384 件2017 年: 被引用 389 件2018 年: 被引用 346 件2019 年: 被引用 1,089 件2020 年: 被引用 1,315 件2021 年: 被引用 1,253 件2022 年: 被引用 1,058 件2023 年: 被引用 997 件2024 年: 被引用 1,524 件2025 年: 被引用 761 件2026 年: 被引用 21 件1968〜1970 年は被引用が無いため表示していません1972〜1979 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,987 件、この内訳の 31%中国: 引用元論文 1,400 件、この内訳の 7.3%イギリス: 引用元論文 1,299 件、この内訳の 6.7%イタリア: 引用元論文 910 件、この内訳の 4.7%カナダ: 引用元論文 853 件、この内訳の 4.4%ドイツ: 引用元論文 842 件、この内訳の 4.4%フランス: 引用元論文 730 件、この内訳の 3.8%オランダ: 引用元論文 617 件、この内訳の 3.2%スペイン: 引用元論文 544 件、この内訳の 2.8%オーストラリア: 引用元論文 518 件、この内訳の 2.7%スイス: 引用元論文 434 件、この内訳の 2.2%日本: 引用元論文 422 件、この内訳の 2.2%
0%31%その他 24.6%

分野

  • Medicine52.2%
  • Biochemistry, Genetics and Molecular Biology27.3%
  • Computer Science5.9%
  • Mathematics3%
  • Decision Sciences2.6%
  • Engineering2.1%
  • その他6.9%

トピック

  • Breast Cancer Treatment Studies7.3%
  • HER2/EGFR in Cancer Research3.8%
  • Cancer Genomics and Diagnostics2.6%
  • Breast Lesions and Carcinomas2.5%
  • Global Cancer Incidence and Screening2.5%
  • Cancer Immunotherapy and Biomarkers2.2%
  • その他79.1%

共著者

全論文

検索で開く
  1. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

    著者: , , , , , , , , , , , , , , , - Alzheimer s Research & Therapy 2021 被引用: 817

  2. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen Y. Chui, Amy S. Clark, Julia L. Clennell, Brian Datnow, Angela M. DeMichele, Xiuzhen Duan, Kirsten K. Edmiston, Anthony D. Elias, Erin D. Ellis, Laura L. Esserman, David M. Euhus, Oluwole Fadare, Fang Fan, Michael D Feldman, Andres Forero-Torres, Barbara B. Haley, Hyo S. Han, Shuko Harada, Patricia Haugen, Teresa Helsten, Gillian L. Hirst, Nola M. Hylton, Claudine Isaacs, Kathleen Kemmer, Qamar J. Khan, Laila Khazai, Molly E. Klein, Gregor Krings, Julie E. Lang, Lauren G. LeBeau, Brian Leyland-Jones, Minetta C. Liu, Shelly Lo, Janice Lu, Anthony Magliocco, Jeffrey B. Matthews, Michelle E. Melisko, Paulette Mhawech-Fauceglia, Stacy L. Moulder, Rashmi K. Murthy, Rita Nanda, Donald W. Northfelt, Idris T. Ocal, Olufunmilayo Olopade, Stefan Pambuccian, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Garry Peterson, Lajos Pusztai, Mara Rendi, Hope S. Rugo, Sunati Sahoo, Sharon Sams, Ashish Sanil, Husain Sattar, Richard B. Schwab, Ruby Singhrao, Katherine Steeg, Erica Stringer-Reasor, W. Fraser Symmans, Ossama Tawfik, Debasish Tripathy, Megan L. Troxell, Laura J. van't Veer, Sara J. Venters, Tuyethoa Vinh, Rebecca K. Viscusi, Anne M. Wallace ほか 37 名 - The Lancet Oncology 2021 被引用: 437

  3. openalex_id:w4200350191

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen‐John Sammut, Jeremy Thomas, David Cameron, A Graham, Peter S Hall, Lorna Mackintosh, Fang Fan, Andrew K. Godwin, Kelsey Schwensen, Priyanka Sharma, Angela DeMichele, Kimberly Cole, Lajos Pusztai, Mi‐Ok Kim, Laura van ‘t Veer, Laura Esserman, W. Fraser Symmans, Kathi Adamson, Kathy S. Albain, Adam L. Asare, Smita Asare, Ronald Balassanian, Heather Beckwith, Scott Berry, Donald A. Berry, Meredith Buxton, Yunn‐Yi Chen, Beiyun Chen, A. Jo Chien, Jane Yuet Ching Hui, Amy S. Clark, Julia L. Clennell, Brian Datnow, Xiuzhen Duan, Kirsten K. Edmiston, Anthony Elias, Erin D. Ellis, David Euhus, Oluwole Fadare, Michael D. Feldman, Andres Forero‐Torres, Barbara Haley, Hyo S. Han, Shuko Harada, Patricia Haugen, Teresa Helsten, Gillian L. Hirst, Nola M. Hylton, Claudine Isaacs, Kathleen Kemmer, Qamar J. Khan, Laila Khazai, Molly Klein, Gregor Krings, Julie E. Lang, Lauren LeBeau, Brian Leyland‐Jones, Minetta C. Liu, Shelly S. Lo, Janice Lu, Anthony M. Magliocco, Jeffrey B. Matthews, Michelle Melisko, Paulette Mhawech‐Fauceglia, Stacy L. Moulder, Rashmi K. Murthy, Rita Nanda, Donald W. Northfelt, Idris Tolgay Ocal, Olufunmilayo I. Olopade ほか 28 名 被引用: 353

  4. Evaluation of cell-free DNA approaches for multi-cancer early detection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristan K. Steffen, Virgil Nicula, Tom C. Chien, Siddhartha Bagaria, Nathan Hunkapiller, Mohini Desai, Dong Zhao, Donald Richards, Timothy J. Yeatman, Allen Lee Cohn, David D. Thiel, Donald A. Berry, Mohan K. Tummala, Kristi McIntyre, Mikkael A. Sekeres, Alan H. Bryce, Alexander M. Aravanis, Michael V. Seiden, Charles Swanton - Cancer Cell 2022 被引用: 314

  5. Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey B. Matthews, Scott Berry, Ashish Sanil, Richard B. Schwab, W. Fraser Symmans, Laura van ‘t Veer, Douglas Yee, Angela DeMichele, Nola M. Hylton, Michelle Melisko, Jane Perlmutter, Hope S. Rugo, Donald A. Berry, Laura J. Esserman - JAMA Oncology 2020 被引用: 706

  6. Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gillian L. Hirst, Laura J. Esserman, Laura van ‘t Veer - Cancer Cell 2022 被引用: 326

  7. Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott Berry, Ashish Sanil, Adam L. Asare, Jeffrey B. Matthews, Jane Perlmutter, Michelle Melisko, Hope S. Rugo, Richard B. Schwab, W. Fraser Symmans, Douglas Yee, Laura J. van’t Veer, Nola M. Hylton, Angela DeMichele, Donald A. Berry, Laura J. Esserman - Cancer Cell 2021 被引用: 330

  8. Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , - JAMA Oncology 2020 被引用: 368

  9. Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 被引用: 1,030

  10. Analysis of Breast Cancer Mortality in the US—1975 to 2019

    著者: , , , , , , , , , , , , , , , , , , - JAMA 2024 被引用: 271

  11. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren ほか 136 名 - The Lancet 2023 被引用: 189

  12. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber ほか 67 名 - The Lancet 2019 被引用: 394

  13. Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

    著者: , , , , , , , , , , , , , , , , , - JAMA 2010 被引用: 1,170

  14. Meta-analyses of colorectal cancer risk factors

    著者: , , , , , , - Cancer Causes & Control 2013 被引用: 778

  15. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 1,459

  16. Benefits and Harms of CT Screening for Lung Cancer

    著者: , , , , , , , , , , , , , , - JAMA 2012 被引用: 1,252

  17. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , - JAMA Oncology 2017 被引用: 568

  18. Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 1,301

  19. Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erica Stringer-Reasor, Anne M. Wallace, Lajos Pusztai, Judy C. Boughey, Erin D. Ellis, Anthony Elias, Janice Lu, Julie E. Lang, Hyo S. Han, Amy S. Clark, Rita Nanda, Donald W. Northfelt, Qamar J. Khan, Rebecca K. Viscusi, David Euhus, Kirsten K. Edmiston, Jane Yuet Ching Hui, Kathleen Kemmer, John W. Park, Minetta C. Liu, Olufunmilayo I. Olopade, Brian Leyland‐Jones, Debasish Tripathy, Stacy L. Moulder, Hope S. Rugo, Richard B. Schwab, Shelly S. Lo, Teresa Helsten, Heather Beckwith, Patricia Haugen, Nola M. Hylton, Laura J. van’t Veer, Jane Perlmutter, Michelle Melisko, Amy Wilson, Garry Peterson, Adam L. Asare, Meredith Buxton, Melissa Paoloni, Julia L. Clennell, Gillian L. Hirst, Ruby Singhrao, Katherine Steeg, Jeffrey B. Matthews, Smita Asare, Ashish Sanil, Scott Berry, Laura J. Esserman, Donald A. Berry - JAMA Oncology 2020 被引用: 225

  20. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Song Gao, Julianne Pollard‐Larkin, P Nitsch, R Sadagopan, Xiaochun Wang - The Lancet Oncology 2021 被引用: 312

  21. Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Haley, Rita Nanda, Donald W. Northfelt, Debasish Tripathy, William C. Wood, Cheryl A. Ewing, Richard B. Schwab, Julia Lyandres, Sarah Davis, Gillian L. Hirst, Ashish Sanil, Donald A. Berry, Laura J. Esserman - New England Journal of Medicine 2016 被引用: 555

  22. Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes

    著者: , , , , , , , , , , , , , - JAMA Oncology 2016 被引用: 375

  23. Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2003 被引用: 1,564

  24. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M.M. Eggermont, Michael A. Davies, Miles C. Andrews, Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shaneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Paolo A. Ascierto, Andrew J. Spillane, Alexander C. J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long - The Lancet Oncology 2019 被引用: 218